UK biotech Oxford BioTherapeutics (OBT), a clinical stage oncology company with a pipeline of immuno-oncology (I-O) and ...

With a keen eye for financial strategy and a passion for scientific innovation, Glenn’s arrival at Auron marks the beginning of a new chapter in our mission to improve patient lives,” said Kate Yen, ...

Roche, which put billions on the line a year ago across several ADC pacts, kicked off 2025 by returning to Innovent Biologics ...

China health care companies received a significant reprieve in terms of geopolitical risks when the US Senate declined to ...

Communiqué de la société OXURION du 18/03/2025 - Oxurion signs a letter of intent for the planned acquisition of a biometrics-focused CRO ...

Access the CEO Connect segment hereLA JOLLA, CA, March 18, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a ...

Cloud-based Elite™ platform to roll out to Roche's laboratory network across 50+ countries and a target 1,000 installations over five years.

A new precision oncology paper was published in Oncotarget, Volume 16, on March 12, 2025, titled “Worldwide Innovative ...

Real estate developer Alameda claimed bio-tech entrepreneur Patrick Soon-Shiong and lease guarantor NantMedia breached the ...

Another company involved in using AI to repurpose failed drugs – as well as drugs that have already been approved – is ...

Therapy receives FDA Orphan Drug Designation for PEP-010for treatment of Pancreatic CancerParis (France), March 17, 2025 – ...